Maspin and Bax Proteins in Cholangiocarcinoma
Author Information
Author(s): Romani Antonello A, Soliani Paolo, Desenzani Silvia, Borghetti Angelo F, Crafa Pellegrino
Primary Institution: Università degli Studi di Parma
Hypothesis
The associated expression of Maspin and Bax proteins may serve as a prognostic factor in intrahepatic cholangiocarcinoma.
Conclusion
The expression of Maspin and Bax may delay tumor progression in intrahepatic cholangiocarcinoma by influencing apoptosis.
Supporting Evidence
- Maspin expression was present in 77% of the intrahepatic cholangiocarcinoma samples analyzed.
- A Maspin HSCORE above the cutpoint was inversely related to tumor dimension and vascular invasion.
- Patients with a Maspin HSCORE below the cutpoint had a shorter survival compared to those above the cutpoint.
Takeaway
Maspin and Bax are proteins that can help fight cancer by making cancer cells die when they should. If there's more Maspin, it can help slow down the growth of a specific type of liver cancer.
Methodology
Immunohistochemical analysis of paraffin-embedded samples from patients with intrahepatic cholangiocarcinoma.
Potential Biases
Potential selection bias due to the small cohort and single-institution study design.
Limitations
The study had a small sample size, limiting the generalizability of the findings.
Participant Demographics
22 patients (9 males and 13 females) with an average age of 68 years.
Statistical Information
P-Value
0.039
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website